The data herein demonstrate that MTDIA and AG-270 have synergistic effects in reducing cell growth in vitro through the increase in the MTA:SAM metabolite ratio that inhibits PRMT5 activity and resulting in downstream effects on RNA splicing activity, p53 activation, cell growth arrest, and tumor growth inhibition in murine xenograft models. Here, PRMT5 is linked to neoplasm.